Pay in 4 interest-free payments of $6.60 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Lilly's tirzepatide led to greater improvements in liver fat content compared to insulin degludec in adults with type 2 diabetes in SURPASS-3 MRI sub-study Participants taking tirzepatide 15 mg experienced 47.11% relative reduction in liver fat content compared to 11.17% for insulin degludec Volume of abdominal adipose tissue decreased with tirzepatide, compared to an increase with insulin degludec 1 The results were presented today at the 57 th The MRI (magnetic resonance imaging) sub-study achieved its primary and secondary endpoints
Results demonstrated dose-dependent MASH resolution without worsening fibrosis in 51.8%, 62.8%, and 73.3% of participants taking 5mg, 10mg, and 15mg doses respectively, versus merely 13.2% with placebo
Dose escalation over the first months, product form, and whether you're on a brand or compounded formulation all feed into it which is why two members of the same program can pay very different amounts
At this time, more research is needed to understand how GLP-1 medications may affect milk supply long term
You should consult your provider if: You are currently experiencing severe side effects on your current schedule
